Vendor review
Mokemei Zhengzhou Biotechnology MKM reviews
Mokemei Zhengzhou Biotechnology MKM reviews from 35 independent lab tests (Retatrutide, GHK-Cu and BPC-157): grade A, purity and fill accuracy. Is Mokemei Zhengzhou Biotechnology MKM legit? See what its vials showed.
What the lab tests show
35 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 14, 2026 | Retatrutide | 99.99 % | 35.76 mg of 30 mg (19 %) | Pass | View |
| Oct 1, 2026 | TB-500 | 99.9 % | 9.59 mg of 10 mg (-4 %) | Pass | View |
| Sep 30, 2026 | BPC-157 | 99.99 % | 10.03 mg of 10 mg (0 %) | Pass | View |
| Sep 29, 2026 | Retatrutide | 99.99 % | 18.85 mg of 15 mg (26 %) | Pass | View |
| Sep 25, 2026 | Retatrutide | 30 % | 8.99 mg of 30 mg (-70 %) | Pass | View |
| Sep 24, 2026 | TB-500 | 99.9 % | 9.21 mg of 10 mg (-8 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 60 mg | Fail | View | |
| Sep 24, 2026 | BPC-157 | 99.9 % | 9.99 mg of 10 mg (0 %) | Pass | View |
| Sep 24, 2026 | BPC-157 | 99.9 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Sep 24, 2026 | GHK-Cu | 99.9 % | 55.3 mg of 50 mg (11 %) | Pass | View |
| Sep 24, 2026 | GHK-Cu | 99 % | 98.3 mg of 100 mg (-2 %) | Pass | View |
| Sep 24, 2026 | Epithalon | 98.7 % | 43.9 mg of 50 mg (-12 %) | Pass | View |
| Sep 18, 2026 | Retatrutide | 99.9 % | 9.16 mg of 10 mg (-8 %) | Pass | View |
| Sep 15, 2026 | GHK-Cu | 99.9 % | 57.3 mg of 50 mg (15 %) | Pass | View |
| Sep 4, 2026 | Retatrutide | 35.4 % | 4.57 mg of 30 mg (-85 %) | Pass | View |
| Aug 12, 2026 | BPC-157 | 99.5 % | 11.8 mg of 10 mg (18 %) | Pass | View |
| Aug 12, 2026 | Epithalon | 99 % | 9.31 mg of 10 mg (-7 %) | Pass | View |
| Jul 23, 2026 | GHK-Cu | 99.9 % | 13.2 mg of 100 mg (-87 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 99.9 % | 47.5 mg of 40 mg (19 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.8 % | 17.8 mg of 20 mg (-11 %) | Pass | View |
| Jul 17, 2026 | Retatrutide | 10 mg | Fail | View | |
| Jul 9, 2026 | Retatrutide | 30 mg | Fail | View | |
| Jul 1, 2026 | Epithalon | 10 mg | Fail | View | |
| Jun 24, 2026 | Retatrutide | 99.2 % | 9.68 mg of 10 mg (-3 %) | Pass | View |
| Jun 23, 2026 | GHK-Cu | 99.9 % | 41.1 mg of 50 mg (-18 %) | Pass | View |
| Jun 12, 2026 | GHK-Cu | 99.9 % | 43.7 mg of 50 mg (-13 %) | Pass | View |
| Jun 1, 2026 | Retatrutide | 99.8 % | 60.4 mg of 60 mg (1 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 14.9 mg of 15 mg (-1 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 16 mg of 15 mg (7 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 12.5 mg of 10 mg (25 %) | Pass | View |
| Feb 22, 2026 | GHK-Cu | 99.57 % | 32.6 mg of 10 mg (226 %) | Pass | View |
| Nov 17, 2025 | Retatrutide | 99.67 % | 39.4 mg of 40 mg (-2 %) | Pass | View |
| Nov 14, 2025 | BPC-157 | 99.9 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Oct 23, 2025 | Retatrutide | 99.95 % | 4.12 mg of 5 mg (-18 %) | Pass | View |
| Sep 1, 2025 | Tirzepatide | 99.82 % | 63.64 mg of 60 mg (6 %) | Pass | View |
What Mokemei Zhengzhou Biotechnology MKM sells
No current listings on record.
About Mokemei Zhengzhou Biotechnology MKM
Finnrick has tested 35 samples from Mokemei Zhengzhou Biotechnology MKM across 6 products.